| 发明名称 |
SYNERGISTIC TUMOR TREATMENT WITH EXTENDED-PK IL-2 AND THERAPEUTIC AGENTS |
| 摘要 |
The present invention relates to methods of treating cancer with a combination of extended-PK IL-2 and one or more therapeutic agents, such as a therapeutic antibody. The methods of the invention are applicable across any type of cancer. |
| 申请公布号 |
US2015132254(A1) |
申请公布日期 |
2015.05.14 |
| 申请号 |
US201314402889 |
申请日期 |
2013.05.21 |
| 申请人 |
Massachusetts Institute of Technology |
发明人 |
Wittrup Karl Dane;Kwan Byron Hua;Gai Shuning |
| 分类号 |
A61K38/20;A61K45/06;A61K47/48;A61K39/395;A61K38/38 |
主分类号 |
A61K38/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method for treating cancer in a subject comprising administering an extended-pharmacokinetic (PK) interleukin (IL)-2, and a therapeutic agent in an amount effective to treat cancer. |
| 地址 |
Cambridge MA US |
